← all works
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.
No Canadian affiliation. An affiliation-only frame — the usual design — would never have seen this work. It is one of the works that make the case for inverting the frame.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- Nature
- Topic
- SARS-CoV-2 and COVID-19 Research
- Field
- Medicine
- Canadian institutions
- —
- Funders
- NIHR BioResourceDirectorate for Biological SciencesNational Institutes of HealthUniversity Hospitals Coventry and Warwickshire NHS TrustWarwick Medical SchoolQuadram Institute BioscienceOxford University Hospitals NHS Foundation TrustCambridge University HospitalsPublic Health AgencySwansea UniversityPublic Health EnglandQueen's University BelfastUniversity of BirminghamUniversity of WarwickUniversity of OxfordUniversity of SouthamptonWellcome TrustCancer Research UKUniversity College LondonQueen's UniversityUniversity of East AngliaNational Institute for Health and Care ResearchUniversity of CambridgeNIHR Cambridge Biomedical Research CentreAcademy of Medical SciencesFast GrantsNational Institute of Allergy and Infectious DiseasesUniversity Hospital Southampton NHS Foundation TrustKing's College Hospital NHS Foundation TrustUniversity of ExeterNorthumbria UniversityNational Institute of General Medical SciencesPublic Health WalesBurroughs Wellcome FundBill and Melinda Gates FoundationFordham UniversityMedical Research CouncilDepartment of Health and Social CareVir BiotechnologyKing's College LondonUniversity of Portsmouth
- Keywords
- VirologyAntibodyMonoclonal antibodyNeutralizationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ReceptorBiologyNeutralizing antibodySpike ProteinMessenger RNAVirusCoronavirus disease 2019 (COVID-19)MedicineGeneImmunologyGeneticsInfectious disease (medical specialty)
- Has abstract in OpenAlex
- no